As CIDP moves toward targeted therapies and patient-friendly regimens, the market is primed for disruption—offering a fresh ...

A new trial finds that intravenous immunoglobulin stabilises kidney function and slows damage in patients with chronic ...

Therapeutic plasma exchange combined with intravenous immunoglobulin reduced biological age on average by 2.6 years, as ...

A subcutaneous formulation of MSD's top-selling cancer immunotherapy, Keytruda, was non-inferior to the current intravenous version in a head-to-head trial, setting up regulatory filings.

New 100-week data from the ongoing Phase I/II study of zigakibart, an investigational anti-APRIL monoclonal antibody, ...

A formulation of MSD's cancer drug Keytruda that can be given by subcutaneous injection rather than intravenous infusion has cleared a phase 3 trial, setting up approvals later this year.

Due to the autoimmune etiology of this disorder, IV immunoglobulin (IVIg) or plasma exchange (PE) are the first-line treatments in addition to management of ventilatory failure. IVIg is more ...

Though they are both multiple myeloma drugs with the same mechanism of action, Sanofi’s Sarclisa has had difficulty competing ...

The jugular or the subclavian vein was used in each of these patients, and the subcutaneous valves were placed on the upper chest wall. The authors reported a mean duration of device survival of 6 ...

Recent measles outbreaks in Canada and continued feasibility challenges of using human immunoglobulin products during measles outbreaks prompted NACI to revisit guidance on measles PEP. In 2018, NACI ...

Correspondence to Dr Justin F Fraser, Departments of Neurological Surgery, Neurology, Radiology, and Neuroscience, University of Kentucky, Lexington KY 40536, USA; Jfr235{at}uky.edu Defining the ...

Corticosteroids alone or combined with other agents (intravenous IG or plasmapheresis ... 74% for patients presenting with faciobrachial dystonic seizures, 63% for NMDAR-IgG encephalitis and 48.5% for ...